{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,4]],"date-time":"2022-04-04T17:23:13Z","timestamp":1649092993149},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2012,8,18]],"date-time":"2012-08-18T00:00:00Z","timestamp":1345248000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern Emerg Med"],"published-print":{"date-parts":[[2012,10]]},"DOI":"10.1007\/s11739-012-0840-7","type":"journal-article","created":{"date-parts":[[2012,8,16]],"date-time":"2012-08-16T23:36:50Z","timestamp":1345160210000},"page":"395-397","source":"Crossref","is-referenced-by-count":1,"title":["Pulmonary hypertension: have we learned enough yet?"],"prefix":"10.1007","volume":"7","author":[{"given":"Davide","family":"Cattano","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie Francoise","family":"Doursout","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,8,18]]},"reference":[{"issue":"6 Suppl","key":"840_CR1","doi-asserted-by":"crossref","first-page":"62S","DOI":"10.1378\/chest.09-2845","volume":"137","author":"BK Sastry","year":"2010","unstructured":"Sastry BK, McGoon MD, Gibbs JS (2010) Clinical trials for pulmonary hypertension in the developing world: pulmonary vascular disease: the global perspective. Chest 137(6 Suppl):62S\u201368S","journal-title":"Chest"},{"issue":"1 Suppl","key":"840_CR2","doi-asserted-by":"crossref","first-page":"S55","DOI":"10.1016\/j.jacc.2009.04.011","volume":"54","author":"DB Badesch","year":"2009","unstructured":"Badesch DB, Champion HC, Sanchez MA, Hoeper MM, Loyd JE, Manes A, McGoon M, Naeije R, Olschewski H, Oudiz RJ, Torbicki A (2009) Diagnosis and assessment of pulmonary arterial hypertension. J Am Coll Cardiol 54(1 Suppl):S55\u2013S66","journal-title":"J Am Coll Cardiol"},{"key":"840_CR3","unstructured":"Terrie YC (2010) Pulmonary arterial hypertension: keeping patients informed. Pharmacy Times (published online: December 13). http:\/\/www.pharmacytimes.com\/publications\/issue\/2010\/December2010\/Counseling-1210"},{"issue":"4 Pt 1","key":"840_CR4","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/S0761-8425(07)91571-5","volume":"24","author":"R Naeije","year":"2007","unstructured":"Naeije R, Dewachter L (2007) [Animal models of pulmonary arterial hypertension]. Rev Mal Respir 24(4 Pt 1):481\u2013496","journal-title":"Rev Mal Respir"},{"issue":"1","key":"840_CR5","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.ccm.2006.11.007","volume":"28","author":"ED Austin","year":"2007","unstructured":"Austin ED, Loyd JE (2007) Genetics and mediators in pulmonary arterial hypertension. Clin Chest Med 28(1):43\u201357","journal-title":"Clin Chest Med"},{"issue":"1","key":"840_CR6","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S0002-9440(10)63115-X","volume":"164","author":"S Greenway","year":"2004","unstructured":"Greenway S, van Suylen RJ, Du Marchie Sarvaas G, Kwan E, Ambartsumian N, Lukanidin E, Rabinovitch M (2004) S100A4\/Mts1 produces murine pulmonary artery changes resembling plexogenic arteriopathy and is increased in human plexogenic arteriopathy. Am J Pathol 164(1):253\u2013262","journal-title":"Am J Pathol"},{"key":"840_CR7","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1007\/978-1-60761-500-2_28","volume":"661","author":"F Grimminger","year":"2010","unstructured":"Grimminger F, Schermuly RT (2010) PDGF receptor and its antagonists: role in treatment of PAH. Adv Exp Med Biol 661:435\u2013446","journal-title":"Adv Exp Med Biol"},{"key":"840_CR8","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0076-6879(07)00415-6","volume":"439","author":"M Oka","year":"2008","unstructured":"Oka M, Homma N, McMurtry IF (2008) Rho kinase-mediated vasoconstriction in rat models of pulmonary hypertension. Methods Enzymol 439:191\u2013204","journal-title":"Methods Enzymol"},{"issue":"4","key":"840_CR9","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1183\/09031936.00114407","volume":"32","author":"RT Schermuly","year":"2008","unstructured":"Schermuly RT, Stasch JP, Pullamsetti SS, Middendorff R, M\u00fcller D, Schl\u00fcter KD, Dingendorf A, Hackemack S, Kolosionek E, Kaulen C, Dumitrascu R, Weissmann N, Mittendorf J, Klepetko W, Seeger W, Ghofrani HA, Grimminger F (2008) Expression and function of soluble guanylate cyclase in pulmonary arterial hypertension. Eur Respir J 32(4):881\u2013891","journal-title":"Eur Respir J"},{"issue":"4","key":"840_CR10","doi-asserted-by":"crossref","first-page":"L658","DOI":"10.1152\/ajplung.00189.2009","volume":"297","author":"N Weissmann","year":"2009","unstructured":"Weissmann N, Hackemack S, Dahal BK, Pullamsetti SS, Savai R, Mittal M, Fuchs B, Medebach T, Dumitrascu R, Eickels M, Ghofrani HA, Seeger W, Grimminger F, Schermuly RT (2009) The soluble guanylate cyclase activator HMR1766 reverses hypoxia-induced experimental pulmonary hypertension in mice. Am J Physiol Lung Cell Mol Physiol 297(4):L658\u2013L665","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"2","key":"840_CR11","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1164\/rccm.200702-264OC","volume":"177","author":"F Kamezaki","year":"2008","unstructured":"Kamezaki F, Tasaki H, Yamashita K, Tsutsui M, Koide S, Nakata S, Tanimoto A, Okazaki M, Sasaguri Y, Adachi T, Otsuji Y (2008) Gene transfer of extracellular superoxide dismutase ameliorates pulmonary hypertension in rats. Am J Respir Crit Care Med 177(2):219\u2013226","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"840_CR12","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1513\/pats.200605-128JG","volume":"4","author":"TM Bull","year":"2007","unstructured":"Bull TM, Coldren CD, Geraci MW, Voelkel NF (2007) Gene expression profiling in pulmonary hypertension. Proc Am Thorac Soc 4(1):117\u2013120","journal-title":"Proc Am Thorac Soc"},{"issue":"6","key":"840_CR13","first-page":"44","volume":"39","author":"J Woodcock","year":"2005","unstructured":"Woodcock J (2005) Pharmacogenetics: on the road to \u2018personalized medicine\u2019. FDA Consum 39(6):44","journal-title":"FDA Consum"},{"issue":"24","key":"840_CR14","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1056\/NEJM199306173282402","volume":"328","author":"A Giaid","year":"1993","unstructured":"Giaid A, Yanagisawa M, Langleben D, Michel RP, Levy R, Shennib H, Kimura S, Masaki T, Duguid WP, Stewart DJ (1993) Expression of endothelin-1 in the lungs of patients with pulmonary hypertension. N Engl J Med 328(24):1732\u20131739","journal-title":"N Engl J Med"},{"issue":"5","key":"840_CR15","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1038\/hr.2010.16","volume":"33","author":"R Yamanaka","year":"2010","unstructured":"Yamanaka R, Otsuka F, Nakamura K, Yamashita M, Otani H, Takeda M, Matsumoto Y, Kusano KF, Ito H, Makino H (2010) Involvement of the bone morphogenetic protein system in endothelin- and aldosterone-induced cell proliferation of pulmonary arterial smooth muscle cells isolated from human patients with pulmonary arterial hypertension. Hypertens Res 33(5):435\u2013445","journal-title":"Hypertens Res"},{"key":"840_CR16","doi-asserted-by":"crossref","unstructured":"Calabr\u00f2 P, Limongelli G, Maddaloni V, Vizza CD, D\u2019Alto M, D\u2019Alessandro R, Poscia R, Argiento P, Ziello B, Badagliacca R, Romeo E, Pacileo G, Russo MG,Fedele F, Calabr\u00f2 R (2011) Analysis of endothelin-1 and endothelin-1 receptor A gene polymorphisms in patients with pulmonary arterial hypertension. Intern Emerg Med. doi: 10.1007\/s11739-011-0643-2","DOI":"10.1007\/s11739-011-0643-2"},{"issue":"1","key":"840_CR17","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1097\/00004872-199715010-00005","volume":"15","author":"EL Schiffrin","year":"1997","unstructured":"Schiffrin EL, Deng LY, Sventek P, Day R (1997) Enhanced expression of endothelin-1 gene in resistance arteries in severe human essential hypertension. J Hypertens 15(1):57\u201363","journal-title":"J Hypertens"},{"issue":"1","key":"840_CR18","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/0014-5793(88)80536-2","volume":"239","author":"Y Hirata","year":"1988","unstructured":"Hirata Y, Yoshimi H, Takaichi S, Yanagisawa M, Masaki T (1988) Binding and receptor down-regulation of a novel vasoconstrictor endothelin in cultured rat vascular smooth muscle cells. FEBS Lett 239(1):13\u201317","journal-title":"FEBS Lett"}],"container-title":["Internal and Emergency Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11739-012-0840-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11739-012-0840-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11739-012-0840-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T17:28:43Z","timestamp":1559410123000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11739-012-0840-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,8,18]]},"references-count":18,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2012,10]]}},"alternative-id":["840"],"URL":"https:\/\/doi.org\/10.1007\/s11739-012-0840-7","relation":{},"ISSN":["1828-0447","1970-9366"],"issn-type":[{"value":"1828-0447","type":"print"},{"value":"1970-9366","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,8,18]]}}}